Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This drug entry refers to a specific local anesthetic combination of **mepivacaine** and **lidocaine** (1.5% concentration) used for **pericervical anesthesia** in the context of a clinical trial conducted by the **Ospedale degli Infermi di Biella**. The combination is administered via pericervical infiltration (typically at the 3 and 9 o'clock positions) to manage **procedural pain** during outpatient operative hysteroscopy performed with a miniresector. Both mepivacaine and lidocaine are amide-type local anesthetics that work by blocking voltage-gated sodium channels, thereby inhibiting the initiation and conduction of nerve impulses to provide rapid and effective regional analgesia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on mepivacaine + lidocaine.